The DDHD1 gene helps cells manage certain membrane fats, which supports the health of long nerve cells. This gene plays an important role in keeping the nerves used for walking working normally. If it does not work well, some people develop hereditary spastic paraplegia, an inherited condition that can cause leg stiffness, weakness, and trouble walking.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Other genes mainly direct when, where, and how strongly certain processes happen. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can learn more in the LearnHub.
Overview
DDHD1Gene function
What if the gene works
The DDHD1 gene helps cells process certain fats in membranes. This supports healthy membrane shape and movement inside cells, especially in nerve cells.
Risk
What if the gene does not work
Changes in the DDHD1 gene can cause hereditary spastic paraplegia, with gradually increasing leg stiffness and weakness that often affects walking. Effects can range from milder to more limiting, depending on how much the variant reduces gene function.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice that is specific to a pathogenic or loss-of-function variant in the DDHD1 gene is established. Care is based on symptoms, and the DDHD1 gene is mainly being studied to better understand nerve cell fat pathways rather than to guide current medicines.
Conditions associated with DDHD1
Gene function
What if the gene works
Inside your cells, the DDHD1 gene helps manage some of the fats that form cell membranes. Its protein carefully trims selected lipids so they can be reused and kept in balance. Understanding DDHD1 gene function in cells helps explain how membranes stay flexible, organized, and ready for everyday cell work.
The DDHD1 gene makes an enzyme that cuts certain membrane fats at one position. This lets your cells remodel lipids and reuse key membrane parts.
DDHD1 acts on fats such as phosphatidic acid, a membrane fat that helps cells build and shape membranes. Keeping these fats at the right level supports normal membrane structure and routine cell signaling.
By adjusting membrane fats, this protein supports the normal organization of membranes inside the cell. That helps cell compartments form, move, and interact in a controlled way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DDHD1 gene can change the protein’s shape, stability, or activity on membrane fats, showing how DDHD1 gene variants affect protein function. More disruptive variants, such as those that cut the protein short or disrupt RNA splicing (message editing), may leave little or no working protein. Missense variants may leave some activity but weaken folding or membrane binding. This range can influence whether hereditary spastic paraplegia type 28 starts earlier or appears later with variable features.
How variants are linked to conditions
Pathogenic variants in the DDHD1 gene cause hereditary spastic paraplegia type 28, an inherited condition that mainly leads to gradually increasing leg stiffness and weakness. Symptoms often start in childhood or early adulthood and can make walking harder over time. The link between the DDHD1 gene and hereditary spastic paraplegia type 28 is well established in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DDHD1-related hereditary spastic paraplegia, risk is mainly shaped by genetics rather than lifestyle. It is highest when a child inherits two changed copies of the DDHD1 gene, so family history and parents who are blood relatives can raise the chance in a family. There is not enough evidence to say that diet, exercise, or other daily habits lower this genetic risk.
Inheritance of DDHD1 variants
Variants in the DDHD1 gene are inherited in an autosomal recessive pattern for the well-established DDHD1-related condition, a form of hereditary spastic paraplegia. This means a person usually inherits one altered copy from each parent. Parents who each carry one DDHD1 gene variant often do not have symptoms themselves. For each pregnancy, there is a 25% chance the child inherits both altered copies, a 50% chance the child is a carrier, and a 25% chance the child inherits neither altered copy.
What does my DDHD1 result mean for my family?
For DDHD1, family meaning is usually discussed in the context of an inherited nerve condition that follows a recessive pattern. Close relatives may want to know that parents are often healthy carriers, brothers and sisters could also be affected or be carriers, and other family members may carry the same gene change without knowing it. This can be especially relevant for relatives planning children.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the DDHD1 gene usually uses a blood or saliva sample. In DDHD1 genetic testing for hereditary spastic paraplegia, a lab reads the gene's DNA sequence and may also look for missing or extra pieces. Results can show whether a disease-causing variant is present, absent, or uncertain.
When should I consider getting a genetic test?
Consider DDHD1 genetic testing if you or a close family member has a rare inherited condition with slowly worsening leg stiffness, weakness, and walking problems. It can help confirm whether DDHD1 is the cause, especially when symptoms start younger or run in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the specific type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. Part of the difference comes from how the body absorbs, breaks down, and uses a medicine, and these processes can vary from person to person based on their genes.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at the relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes influence either how strongly a drug affects the body or how the body processes it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, you can visit the LearnHub.
Drugs influenced by the DDHD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response, so questions about medicines, side effects, or your general health are best discussed with your doctor.
History
The DDHD1 gene entered the genetics literature through studies of families with an inherited form of progressive leg stiffness and walking difficulty, later classified as hereditary spastic paraplegia type 28. In the early 2010s, researchers connected DDHD1 variants to this condition, helping explain cases that had remained unsolved for years. Building on this early work, scientists identified affected families in several countries, which confirmed that the gene had a consistent link to this rare neurological condition. As genetic testing became more widely used, DDHD1 was added to gene panels for hereditary spastic paraplegia. Its history is mainly one of careful family based research rather than public attention, but it has helped expand understanding of rare inherited movement conditions.